Free Trial

Ovid Therapeutics (OVID) Institutional Ownership

Ovid Therapeutics logo
$1.25 -0.01 (-0.79%)
Closing price 04:00 PM Eastern
Extended Trading
$1.28 +0.03 (+2.40%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Ovid Therapeutics (NASDAQ:OVID)

Current
Institutional Ownership
Percentage
72.24%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$10.67M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$2.79M
Get OVID Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ovid Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OVID Institutional Buying and Selling by Quarter

Ovid Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Rosalind Advisors Inc.500,000$165K0.1%N/A0.703%
8/15/2025 Rubric Capital Management LP478,533$158K0.0%-91.0%0.673%
8/14/2025 Jane Street Group LLC142,597$47K0.0%N/A0.201%
8/14/2025 Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%
8/13/2025 Marshall Wace LLP164,721$54K0.0%N/A0.232%
8/13/2025 Kennedy Capital Management LLC1,502,329$496K0.0%-13.3%2.113%
8/8/2025 Geode Capital Management LLC643,335$212K0.0%-51.7%0.905%
8/1/2025 Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%
7/11/2025 Assenagon Asset Management S.A.435,620$144K0.0%-22.3%0.613%
6/27/2025 Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/21/2025 Acadian Asset Management LLC2,088,046$650K0.0%+12.8%2.936%
5/16/2025 Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/16/2025 Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%
5/16/2025 Adage Capital Partners GP L.L.C.1,150,000$359K0.0%+15.0%1.617%
5/14/2025 Affinity Asset Advisors LLC667,516$208K0.0%N/A0.939%
5/12/2025 Nuveen LLC119,113$37K0.0%N/A0.168%
5/8/2025 XTX Topco Ltd93,154$29K0.0%N/A0.131%
4/15/2025 Assenagon Asset Management S.A.560,830$175K0.0%+699.9%0.789%
2/17/2025 Velan Capital Investment Management LP70,000$65K0.1%N/A0.099%
2/17/2025 Madison Avenue Partners LP3,722,627$3.48M0.4%-9.6%5.242%
2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC943,416$881K0.1%+50.2%1.329%
2/17/2025 Jacobs Levy Equity Management Inc.291,701$272K0.0%N/A0.411%
2/17/2025 Bridgeway Capital Management LLC229,115$214K0.0%-26.0%0.323%
2/17/2025 Bank of America Corp DE56,733$53K0.0%+49.7%0.080%
2/17/2025 BNP Paribas Financial Markets104,712$98K0.0%-52.5%0.147%
2/14/2025 Adage Capital Partners GP L.L.C.1,000,000$934K0.0%N/A1.408%
2/13/2025 Kennedy Capital Management LLC1,545,387$1.44M0.0%+1.1%2.176%
2/13/2025 Renaissance Technologies LLC107,700$101K0.0%+142.0%0.152%
2/13/2025 ADAR1 Capital Management LLC130,532$122K0.0%+245.8%0.184%
2/12/2025 TLS Advisors LLC680,967$636K1.5%-11.7%0.959%
2/12/2025 Takeda Pharmaceutical Co. Ltd.7,531,996$7.01M26.4%N/A10.607%
2/12/2025 JPMorgan Chase & Co.1,418,306$1.32M0.0%-3.1%1.997%
2/10/2025 Monimus Capital Management LP138,266$129K0.1%N/A0.195%
1/30/2025 Rhumbline Advisers84,078$79K0.0%+22.3%0.118%
1/17/2025 SG Americas Securities LLC37,636$35K0.0%+83.9%0.053%
1/14/2025 Assenagon Asset Management S.A.70,114$65K0.0%-18.7%0.099%
11/19/2024 Barclays PLC84,175$98K0.0%+311.2%0.119%
11/16/2024 Geode Capital Management LLC1,317,330$1.56M0.0%+1.1%1.855%
11/15/2024 Barclays PLC84,175$98K0.0%+311.2%0.119%
11/15/2024 XTX Topco Ltd38,230$45K0.0%+46.2%0.054%
A New Way to Double Your Retirement Income? (Ad)

Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel

Click here to see how to turn your savings into a monthly income machine.
11/15/2024 Jane Street Group LLC38,399$45K0.0%-61.1%0.054%
11/14/2024 Verition Fund Management LLC74,875$88K0.0%N/A0.105%
11/13/2024 BNP Paribas Financial Markets220,401$260K0.0%+4,128.7%0.311%
11/13/2024 FMR LLC50,225$59K0.0%+1,907.4%0.071%
11/5/2024 GSA Capital Partners LLP260,509$307K0.0%+118.0%0.367%
10/23/2024 Assenagon Asset Management S.A.86,289$102K0.0%N/A0.122%
8/16/2024 Driehaus Capital Management LLC1,400,191$1.08M0.0%N/A1.974%
8/13/2024 DCF Advisers LLC41,750$32K0.0%+111.6%0.059%
8/9/2024 Renaissance Technologies LLC141,200$109K0.0%-9.9%0.199%
8/9/2024 Dimensional Fund Advisors LP274,982$211K0.0%-19.6%0.388%
8/1/2024 Rhumbline Advisers69,733$54K0.0%-15.6%0.098%
8/1/2024 FFT Wealth Management LLC489,552$377K0.0%+18.2%0.690%
7/26/2024 Bank of New York Mellon Corp218,163$168K0.0%-5.0%0.308%
5/16/2024 BVF Inc. IL3,853,818$11.75M0.3%-43.7%5.442%
5/15/2024 Price T Rowe Associates Inc. MD17,396$54K0.0%+22.1%0.025%
5/10/2024 Vanguard Group Inc.2,976,308$9.08M0.0%-0.5%4.203%
5/7/2024 SG Americas Securities LLC35,938$110K0.0%-9.7%0.051%
5/7/2024 Empowered Funds LLC128,070$391K0.0%+8.1%0.181%
5/1/2024 BNP Paribas Financial Markets32,162$98K0.0%+74.7%0.045%
4/29/2024China Universal Asset Management Co. Ltd.13,579$41K0.0%+66.0%0.019%
4/24/2024 Assenagon Asset Management S.A.114,265$349K0.0%+45.6%0.162%
2/14/2024 Rubric Capital Management LP5,315,969$17.12M0.4%-2.4%7.521%
2/14/2024 Vestal Point Capital LP85,429$275K0.0%N/A0.121%
2/13/2024 DCF Advisers LLC18,730$60K0.0%-38.4%0.026%
2/6/2024 FFT Wealth Management LLC395,774$1.27M0.1%N/A0.560%
1/24/2024China Universal Asset Management Co. Ltd.8,178$26K0.0%N/A0.012%
1/17/2024 Assenagon Asset Management S.A.78,479$253K0.0%N/A0.111%
1/12/2024 SG Americas Securities LLC39,792$128K0.0%+52.7%0.056%
11/13/2023 Connor Clark & Lunn Investment Management Ltd.81,173$312K0.0%+17.2%0.115%
11/13/2023 Acadian Asset Management LLC1,701,228$6.53M0.0%-4.5%2.407%
11/7/2023 New York State Common Retirement Fund19,110$73K0.0%-28.7%0.027%
11/7/2023 Jump Financial LLC15,811$61K0.0%N/A0.022%
10/13/2023 SG Americas Securities LLC26,064$100K0.0%N/A0.037%
9/21/2023 Barclays PLC11,955$40K0.0%N/A0.017%
8/11/2023 Rubric Capital Management LP5,445,910$17.86M0.8%-22.2%7.714%
8/11/2023 Tejara Capital Ltd112,591$369K0.2%-5.2%0.159%
8/9/2023 DCF Advisers LLC64,764$212K0.1%-5.1%0.092%
8/4/2023 American International Group Inc.28,701$94K0.0%N/A0.041%
7/27/2023EA Series Trust98,952$325K0.0%N/A0.140%
7/25/2023Raymond James & Associates25,000$82K0.0%N/A0.035%
5/15/2023 Madison Avenue Partners LP3,104,603$8.01M1.7%+14.1%4.402%
5/15/2023 Rubric Capital Management LP7,001,124$18.06M0.5%+2.5%9.928%
5/12/2023 Tejara Capital Ltd118,791$306K0.2%+10.5%0.168%
5/11/2023 Acadian Asset Management LLC1,780,873$4.59M0.0%-1.9%2.525%
5/10/2023 Connor Clark & Lunn Investment Management Ltd.30,858$80K0.0%-22.7%0.044%
5/9/2023 Y Intercept Hong Kong Ltd35,116$91K0.0%N/A0.050%
5/1/2023 Virtu Financial LLC17,892$46K0.0%N/A0.025%
2/10/2023 Blair William & Co. IL24,328$45K0.0%-22.1%0.035%
11/14/2022 Rubric Capital Management LP4,516,300$8.31M0.4%+56.7%6.409%
11/10/2022 Stonepine Capital Management LLC1,540,671$2.84M1.3%-55.8%2.188%
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
10/18/2022 Newman Dignan & Sheerar Inc.15,522$29K0.0%N/A0.022%
8/16/2022 Driehaus Capital Management LLC1,343,325$2.89M0.0%+273.2%1.908%
8/12/2022 Ikarian Capital LLC26,831$59K0.0%-96.4%0.038%
8/5/2022 Connor Clark & Lunn Investment Management Ltd.36,748$79K0.0%-57.7%0.052%
7/29/2022 Walker Asset Management LLC43,400$105K0.0%N/A0.062%
7/29/2022 Russell Investments Group Ltd.267,868$574K0.0%-2.9%0.380%
7/27/2022 Assenagon Asset Management S.A.26,362$57K0.0%N/A0.037%
7/25/2022 Walker Asset Management LLC43,400$105K0.0%N/A0.062%
5/12/2022 Acadian Asset Management LLC2,139,290$6.72M0.0%+4.9%3.038%
5/12/2022 Connor Clark & Lunn Investment Management Ltd.86,888$273K0.0%-27.3%0.123%
(Data available from 1/1/2016 forward)

OVID Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OVID shares?

During the previous two years, 47 institutional investors and hedge funds held shares of Ovid Therapeutics. The most heavily invested institutionals were BVF Inc. IL ($11.75M), Vanguard Group Inc. ($9.08M), Takeda Pharmaceutical Co. Ltd. ($7.01M), Madison Avenue Partners LP ($3.48M), JPMorgan Chase & Co. ($1.32M), Driehaus Capital Management LLC ($1.08M), and OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($881K).Learn more on Ovid Therapeutics' institutional investors.

What percentage of Ovid Therapeutics' stock is owned by institutional investors?

72.24% of Ovid Therapeutics' stock is owned by institutional investors. Learn more on OVID's institutional investor holdings.

Which institutional investors have been buying Ovid Therapeutics' stock?

Of the 36 institutional investors that purchased Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Takeda Pharmaceutical Co. Ltd. ($7.53M), Driehaus Capital Management LLC ($1.40M), Adage Capital Partners GP L.L.C. ($1.15M), Assenagon Asset Management S.A. ($691.27K), Affinity Asset Advisors LLC ($667.52K), Rosalind Advisors Inc. ($500K), and FFT Wealth Management LLC ($471.30K).

How much institutional buying is happening at Ovid Therapeutics?

Institutional investors have bought a total of 13,079,790 shares in the last 24 months. This purchase volume represents approximately $10.67M in transactions.

Which of Ovid Therapeutics' major shareholders have been selling company stock?

Of the 12 institutional investors that sold Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rubric Capital Management LP ($4.84M), Geode Capital Management LLC ($687.66K), Madison Avenue Partners LP ($394.15K), Kennedy Capital Management LLC ($230.54K), Goldman Sachs Group Inc. ($187.38K), Assenagon Asset Management S.A. ($141.39K), and BNP Paribas Financial Markets ($115.69K).

How much institutional selling is happening at Ovid Therapeutics?

Institutional investors have sold a total of 6,962,046 shares in the last 24 months. This volume of shares sold represents approximately $2.79M in transactions.



This page (NASDAQ:OVID) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners